Abstract
In subjects affected by trisomy 21 (Down syndrome), hypothyroidism is the most common endocrinological deficit. Plasma zinc levels, which are commonly detected below the normal range in Down patients, are related to some endocrinological and immunological functions; in fact, zinc deficiency has been shown to impair immune response and growth rate. Aims of this study were to evaluate (1) the role of zinc deficiency in subclinical hypothyroidism and (2) thyroid function changes in Down children cyclically supplemented with zinc sulfate. Inverse correlations have been observed between age and triiodotironine (T3) and between zinc and thyroid-stimulating hormone (TSH); higher TSH levels have been found in hypozincemic patients at the beginning of the study. After 6 mo of supplementation, an improvement of thyroid function (TSH levels: 3.96 ± 1.84 vs 2.64 ± 1.33 mUI/mL basally and after 6 mo, respectively) was observed in hypozincemic patients. In the second cycle of supplementation, a similar trend of TSH was observed. At the end of the study, TSH significantly decreased in treated hypozincemic subjects (4.48 ± 1.93 vs 2.96 ± 1.20 mUI/mL) and it was no longer different in comparison to normozincemic patients. We suggest zinc supplementation to the diet in hypozincemic Down children as a simple and useful therapeutic tool.
Similar content being viewed by others
References
S. M. Pueschel and J. C. Pezzullo, Thyroid disfunction in Down’s syndrome,Am. J. Dis. Child. 39, 636–639 (1985).
S. Dinani and S. Carpenter, Down’s syndrome and thyroid disorders,J. Mental Defic. Res. 34, 187–193 (1990).
D. L. Friedman, T. Kastner, S. W. Pond, and D. Rice O’Brien, Thyroid disfunction in individuals with Down syndrome,Arch. Intern. Med. 149, 1990–1993 (1989).
A. T. Cutler, R. Benezra-Obeiter, and J. S. Brink, Thyroid function in young children with Down syndrome,Am. J. Dis. Child. 140, 479–483 (1986).
D. Rubello, G. B. Pozzan, D. Casara, M. E. Girelli, S. Boccato, F. Rigon, et al., Natural course of subclinical hypothyroidism in Down’s syndrome: prospective study and therapeutic considerations,J. Endocrinol. Invest. 17, 35–40 (1995).
R. T. Zori, D. A. Schatz, H. Ostrer, C. A. Williams, R. Spillar, and W. J. Riley, Relationship of autoimmunity to thyroid disfunction in children and adults with Down syndrome,Am. J. Med. Genet. 7(suppl.), 238–241 (1990).
T. Sharav, R. M. Collins, and P. J. Baab, Growth studies in infants and children with Down’s syndrome and elevated levels of thyrotropin,Am. J. Dis. Child. 142, 1302–1306 (1988).
G. Napolitano, G. Palka, S. Lio S. I. Bucci, P. De Remigis, L. Stuppia, et al., Is zinc deficiency a cause of subclinical hypothyroidism in Down syndrome?Ann. Genet. 33, 9–15 (1990).
B. Bjorkstein, O. Back, K. H. Gustavson, G. Hallmans, B. Hagglof, and A. Tarnvick, Zinc and immune function in Down syndrome,Acta Pediatr. Scand. 69, 183–187 (1980).
C. Franceschi, M. Chiricolo, F. Licastro, M. Zannotti, M. Masi, E. Mocchegiani, et al., Oral zinc supplementation in Down syndrome: restoration of thymic endocrine activity and some immune defects,J. Ment. Defic. Res. 32, 168–181 (1988).
N. Fabris, E. Mocchegiani, L. Amadio, M. Zannotti, F. Licastro, and C. Franceschi, Thymic hormone deficiency in normal aging and Down’s syndrome: Is there a primary failure of the thymus?Lancet 1, 983–986 (1984).
A. S. Prasad, Clinical, endocrinological and biochemical effects of zinc deficiency,Clin. Endocrinol. Metab. 14, 567–589 (1985).
T. Nakamura, S. Nishiyama, Y. Futagoishi-Suginohara, I. Matsuda, and A. Higashi, Mild to moderate zinc deficiency in short children: effect of zinc supplementation on linear growth velocity,J. Pediatr. 123, 65–69 (1993).
A. E. Favier, Hormonal effects of zinc on growth in children,Biol. Trace Element Res. 32, 383–398 (1992).
S. Z. Ghavami-Maibodi, P. J. Collipp, M. Castro-Magana, C. Stewart, and S. Y. Chen, Effect of oral zinc supplementation on growth, hormonal levels and zinc in healthy short children,Ann. Nutr. Metab. 27, 214–219 (1983).
M. Sustrova and V. Strbak, Thyroid function and plasma immunoglobulins in subjects with Down’s syndrome (DS) during ontogenesis and zinc therapy,J. Endocrinol. Invest. 17, 385–390 (1994).
R. K. Chondra, Excessive intake of zinc impairs immune responses,J. Am. Med. Assoc. 252, 1443–1446 (1984).
J. Neve, Clinical implications of trace elements in endocrinology,Biol. Trace Element Res. 32, 173–185 (1992).
R. J. McConnell, C. E. Menendez, F. Rees Smith, R. I. Henkin, and R. S. Rivlin, Defect of taste and smell in patients with hypothyroidism,Am. J. Med. 59, 354–364 (1976).
K. Aihara, Y. Nishi, S. Hatano, M. Kimara, K. Yoshimitsu, N. Takeichi, et al., Zinc, copper, manganese and selenium metabolism in thyroid diseases,Am. J. Clin. Nutr. 40, 26–35 (1984).
K. Yoshida, J. Kiso, T. Watanabe, K. Kaise, N. Kaise, H. Fukazawa, et al., Erythrocyte zinc concentration in patients with subacute thyroiditis,J. Clin. Endocrinol. Metab. 70, 788–791 (1990).
E. Dolev, P. A. Deuster, B. Solomon, U. H. Trostmann, L. Wartofsky, and K. D. Burman, Alterations in magnesium and zinc metabolism in thyroid diseases,Metabolism 37, 61–67 (1988).
S. Nishiyama, Y. Futagoishi-Suginohara, M. Matsukura, T. Nakamura, A. Higashi, M. Shinohara, et al., Zinc supplementation alters thyroid hormone metabolism in disabled patients with zinc deficiency,J. Am. Coll. Nutr. 13, 62–67 (1994).
F. Arreola, R. Paniagua, A. Perez, S. Diaz-Bensussen, E. Junco, S. Villalpando, et al., Effect of zinc treatment on serum thyroid hormones in uremic patients under peritoneal dialysis,Horm. Metab. Res. 25, 539–542 (1993).
F. Licastro, E. Mocchegiani, M. Zannotti, G. Arena, M. Masi, and N. Fabris, Zinc affects the metabolism of thyroid hormones in children with Down’s syndrome: normalization of thyroid stimulating hormone and reversal triiodothyronine plasmic levels by dietary zinc supplementation,Int. J. Neurosci. 65, 259–268 (1992).
J. O. Oliver, D. S. Sachan, P. Su, and M. Applehans, Effects of zinc deficiency on thyroid function,Drug-Nutrient. Interact. 5, 113–124 (1987).
Essential trace elements and thyroid hormones [Editorial],Lancet 339, 1575–1576 (1992).
J. Lejeune, M. Peeters, M. C. De Blois, M. Bergere, A. Grillot, M. O. Rethore, et al, Function thyroidienne et trisomie21; exces de TSH et deficit en rT3,Ann. Genet. (Paris) 31, 137–143 (1988).
I. J. Ramirez, M. Halwer, L. E. Shapiro, and M. I. Surks, Zinc (II) inhibits the release of thyroid and glucocorticoid receptor from chromatin of cultured GC cells,Horm. Metab. Res. 23, 155–161 (1991).
T. Miyamoto, A. Sakurai, and L. J. De Groot, Effects of zinc and other divalent metals on deoxyribonucleic acid binding and hormone-binding activity on human αl thyroid hormone receptor expressed inEscherichia Coli, Endocrinology129, 3027–3033 (1991).
N. Fabris, E. Mocchegiani, S. Mariotti, F. Pacini, and A. Pinchera, Thyroid function modulates thymic endocrine activity,J. Clin. Endocrinol. Metab. 62, 474–478 (1986).
N. Fabris, E. Mocchegiani, S. Mariotti, G. Caramia, T. Braccilli, F. Pacini, et al., Thymulin deficiency and low 3,5,3′-triiodothyronine syndrome in infant with low birth weight syndrome,J. Clin. Endocrinol. Metab. 65, 247–252 (1987).
G. Napolitano, I. Bucci, C. Giuliani, G. Palka, S. Lio, E. Mocchegiani, et al., Thyroid function in relation to endocrine thymic activity in Down children before and after zinc supplementation, inProgress in Thyroid Research, A. Gordon, J. Gross, and G. Henneman, eds., Balkema-Brookfield, Rotterdam, pp. 291–293 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bucci, I., Napolitano, G., Giuliani, C. et al. Zinc sulfate supplementation improves thyroid function in hypozincemic down children. Biol Trace Elem Res 67, 257–268 (1999). https://doi.org/10.1007/BF02784425
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02784425